172 related articles for article (PubMed ID: 23047035)
1. Podoplanin promotes cell migration via the EGF-Src-Cas pathway in oral squamous cell carcinoma cell lines.
Inoue H; Miyazaki Y; Kikuchi K; Yoshida N; Ide F; Ohmori Y; Tomomura A; Sakashita H; Kusama K
J Oral Sci; 2012 Sep; 54(3):241-50. PubMed ID: 23047035
[TBL] [Abstract][Full Text] [Related]
2. Podoplanin expression during dysplasia-carcinoma sequence in the oral cavity.
Inoue H; Miyazaki Y; Kikuchi K; Yoshida N; Ide F; Ohmori Y; Tomomura A; Sakashita H; Kusama K
Tumour Biol; 2012 Feb; 33(1):183-94. PubMed ID: 22081310
[TBL] [Abstract][Full Text] [Related]
3. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
[TBL] [Abstract][Full Text] [Related]
4. Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma.
Yamada S; Yanamoto S; Naruse T; Matsushita Y; Takahashi H; Umeda M; Nemoto TK; Kurita H
Pathol Oncol Res; 2016 Jul; 22(3):625-32. PubMed ID: 26874697
[TBL] [Abstract][Full Text] [Related]
5. Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-β1 mediated by podoplanin.
Li YY; Zhou CX; Gao Y
Exp Cell Res; 2018 Aug; 369(1):43-53. PubMed ID: 29719198
[TBL] [Abstract][Full Text] [Related]
6. Migration induced by epidermal and hepatocyte growth factors in oral squamous carcinoma cells in vitro: role of MEK/ERK, p38 and PI-3 kinase/Akt.
Brusevold IJ; Aasrum M; Bryne M; Christoffersen T
J Oral Pathol Med; 2012 Aug; 41(7):547-58. PubMed ID: 22413835
[TBL] [Abstract][Full Text] [Related]
7. Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition.
Chen R; Jin G; Li W; McIntyre TM
J Immunol; 2018 Oct; 201(7):2154-2164. PubMed ID: 30150285
[TBL] [Abstract][Full Text] [Related]
8. The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma.
Mashhadiabbas F; Mahjour F; Mahjour SB; Fereidooni F; Hosseini FS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):240-50. PubMed ID: 22769410
[TBL] [Abstract][Full Text] [Related]
9. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
Lin MC; Huang MJ; Liu CH; Yang TL; Huang MC
Oral Oncol; 2014 May; 50(5):478-84. PubMed ID: 24582885
[TBL] [Abstract][Full Text] [Related]
10. Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.
Ochoa-Alvarez JA; Krishnan H; Pastorino JG; Nevel E; Kephart D; Lee JJ; Retzbach EP; Shen Y; Fatahzadeh M; Baredes S; Kalyoussef E; Honma M; Adelson ME; Kaneko MK; Kato Y; Young MA; Deluca-Rapone L; Shienbaum AJ; Yin K; Jensen LD; Goldberg GS
Oncotarget; 2015 Apr; 6(11):9045-60. PubMed ID: 25826087
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-22 promotes the migration and invasion of oral squamous cell carcinoma cells.
Komine-Aizawa S; Aizawa S; Takano C; Hayakawa S
Immunol Med; 2020 Sep; 43(3):121-129. PubMed ID: 32546118
[TBL] [Abstract][Full Text] [Related]
12. Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling.
Chen HJ; Lin CM; Lee CY; Shih NC; Amagaya S; Lin YC; Yang JS
Int J Oncol; 2013 Aug; 43(2):629-37. PubMed ID: 23754208
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.
Wei LY; Lee JJ; Yeh CY; Yang CJ; Kok SH; Ko JY; Tsai FC; Chia JS
Oral Oncol; 2019 Jan; 88():115-123. PubMed ID: 30616781
[TBL] [Abstract][Full Text] [Related]
14. Rubus idaeus extract suppresses migration and invasion of human oral cancer by inhibiting MMP-2 through modulation of the Erk1/2 signaling pathway.
Huang YW; Chuang CY; Hsieh YS; Chen PN; Yang SF; Shih-Hsuan-Lin ; Chen YY; Lin CW; Chang YC
Environ Toxicol; 2017 Mar; 32(3):1037-1046. PubMed ID: 27322511
[TBL] [Abstract][Full Text] [Related]
15. Receptor for activated C kinase 1 (RACK1): a regulator for migration and invasion in oral squamous cell carcinoma cells.
Li J; Guo Y; Feng X; Wang Z; Wang Y; Deng P; Zhang D; Wang R; Xie L; Xu X; Zhou Y; Ji N; Hu J; Zhou M; Liao G; Geng N; Jiang L; Wang Z; Chen Q
J Cancer Res Clin Oncol; 2012 Apr; 138(4):563-71. PubMed ID: 22207523
[TBL] [Abstract][Full Text] [Related]
16. Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma.
Bhawal UK; Ozaki Y; Nishimura M; Sugiyama M; Sasahira T; Nomura Y; Sato F; Fujimoto K; Sasaki N; Ikeda MA; Tsuji K; Kuniyasu H; Kato Y
Oncology; 2005; 69(3):246-55. PubMed ID: 16127291
[TBL] [Abstract][Full Text] [Related]
17. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
[TBL] [Abstract][Full Text] [Related]
18. MMP-11 promoted the oral cancer migration and Fak/Src activation.
Hsin CH; Chou YE; Yang SF; Su SC; Chuang YT; Lin SH; Lin CW
Oncotarget; 2017 May; 8(20):32783-32793. PubMed ID: 28427180
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
20. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.
Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY
Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]